PillSeek

Reviewed by PillSeek Editorial Team · Last updated

Xalkori

Crizotinib 250 mg;

About This Medication

This medication is a Pink Capsule 21 mm, Capsule with imprint "Pfizer;CRZ;250". It contains Crizotinib 250 mg; of Crizotinib[crizotinib];. This belongs to the Kinase inhibitor pharmacologic class. It is manufactured by Pfizer Laboratories Div Pfizer Inc. For details please contact your physician.

Basic Information

Imprint
Pfizer;CRZ;250
Color
Pink
Shape
Capsule
Size
21 mm

Drug Information

Strength
Crizotinib 250 mg;
Dosage Form
Capsule
RxCUI
1148506

Pharmaceutical Classification

Pharmacologic Class
Kinase inhibitor

Related Medications

Other drugs in the same class: Kinase Inhibitor

Ingredients

Active Ingredients
Crizotinib[crizotinib];
Inactive Ingredients
Silicon dioxide;microcrystalline cellulose;anhydrous dibasic calcium phosphate;magnesium stearate;gelatin, unspecified;titanium dioxide;ferric oxide red;shellac;propylene glycol;ammonia;potassium hydroxide;ferrosoferric oxide;

Additional Information

Manufacturer
Pfizer Laboratories Div Pfizer Inc
Status (Rx/OTC)
Rx
Brand Names
Xalkori

⚠️ Important: This information is for educational purposes only. Do not use this tool for medical diagnosis or treatment decisions. Always consult your pharmacist or healthcare provider for questions about your medications. Read full medical disclaimer.

Pink Capsule Xalkori Crizotinib 250 mg; Pill With Imprint Pfizer;CRZ;250 | PillSeek